News Hormone therapy increases breast cancer risk in transgender women, study finds BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2221 (Published 15 May 2019) Cite this as: BMJ 2019;365:l2221 Article Related content Metrics Responses Peer review Related articles Research Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands Published: 14 May 2019; BMJ 365 doi:10.1136/bmj.l1652 See more Vaginal oestrogen is a treatment on the rise, but is it safe? BMJ February 14, 2024, 384 q384; DOI: https://doi.org/10.1136/bmj.q384 Government accused of complacency after rejecting MPs’ recommendations on menopause BMJ January 25, 2023, 380 p190; DOI: https://doi.org/10.1136/bmj.p190 Pancytopenia in pregnancy BMJ November 23, 2022, 379 e069158; DOI: https://doi.org/10.1136/bmj-2021-069158 Rotherham trust is fined £200 000 for failing to take safeguarding action in the case of four babies BMJ October 27, 2022, 379 o2577; DOI: https://doi.org/10.1136/bmj.o2577 An adolescent girl with acute abdominal pain and abdominal mass BMJ October 20, 2022, 379 e068444; DOI: https://doi.org/10.1136/bmj-2021-068444